After blocking in 5% skimmed milk powder for 2 hours at room temperature, the samples were incubated overnight at 4C with primary antibodies, including ERK1/2 (#9102), p-ERK1/2 (#9101), JNK1/2 (#9252), p-JNK (#9251), p38 MAPK (#9212), and p-p38 MAPK (#9211), which were obtained from Cell Signaling Technology (Beverly, MA, USA), as well as VEGF-a (sc-7269) and Tubulin (sc-8035), which were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA)
Animal findings cannot predict when, or whether, a person would notice a result, and before-and-after claims often leave out other important factors
Injury 0.5 mg BPC-157 anchor, reconstitute the 80 mg vial with 2 mL BAC water
ISBN 978-0-323-66162-1